A practical reference on Synthetic peptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-01-05. Anything still debated is marked as such rather than presented as settled.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | About 1419.5 Da | Calculated from the fifteen-residue sequence |
| Residue count | 15 amino acids | Single-letter sequence GEPPPGKPADDAGLV |
| Compound class | Synthetic peptide | Produced by solid-phase synthesis |
| Synonyms | BPC 157; pentadecapeptide BPC 157 | Naming varies across suppliers and papers |
| Appearance | White to off-white powder | Typical form of the lyophilized material |
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic peptide composed of fifteen amino acids. Its sequence corresponds to part of a protein found in human gastric juice, which is the origin of the "body protection compound" label. In laboratory work the material is treated as a defined research chemical rather than a finished product. Published research has centered on animal models, and the peptide is not an approved medicine in most countries.
The peptide was first described in the early 1990s by a group studying gastric secretions and tissue repair. Its fifteen-residue chain is usually written as GEPPPGKPADDAGLV in single-letter code. The free peptide has the formula C62H98N16O22 and a theoretical mass near 1419.5 daltons. These identifiers are established chemical facts that can be checked against standard peptide databases. There is no ambiguity about the primary structure.
=== 6 March === Sudan filed a case in the International Court of Justice (ICJ) against the United Arab Emirates, accusing it of complicity in genocide by providing weapons to the RSF. Canada imposed sanctions on al-Burhan and Hemedti, citing in part "an unwillingness on the part of the leaders to negotiate an end to the war".
Pharmacological screens to identify endogenous channels and pumps responsible for specific patterning events; Voltage-sensitive fluorescent reporter dyes and genetically encoded fluorescent voltage indicators for the characterization of the bioelectric state in vivo. Panels of well-characterized dominant ion channels that can be misexpressed in cells of interest to alter the bioelectric state in desired ways; and Computational platforms that are coming on-line to assist in building predictive models of bioelectric dynamics in tissues. Compared with the electrode-based techniques, the molecular probes provide a wider spatial resolution and facilitated dynamic analysis over time. Although calibration or titration can be possible, molecular probes are typically semi-quantitative, whereas electrodes provide absolute bioelectric values. Another advantage of fluorescence and other probes is their less-invasive nature and spatial multiplexing, enabling the simultaneous monitoring of large areas of embryonic or other tissues in vivo during normal or pathological pattering processes.
== Further reading == Bran the Blessed in Arthurian Romance by Helaine Newstead. Columbia University Press 1939. The Grail: From Celtic Myth to Christian Symbol by Roger Sherman Loomis. ISBN 0-691-02075-2. From Ritual to Romance by Jessie Weston.
Baroness Louise Casey's report into the standards and culture of the Metropolitan Police is published, and describes critical failings, such as discrimination, the organisation's inability to police itself, failings towards women and children, and the loss of public confidence in the service. 22 March Data released for February shows that inflation increased from 10.1% to 10.4%, largely due to an increase in the cost of fresh food (particularly vegetables), non-alcoholic drinks, restaurant meals, and women's clothes. A major incident is declared, with 35 injuries reported, after the 76m-long RV Petrel research vessel tips over at a dock in Leith. Boris Johnson gives evidence to the cross-party Privileges Committee, relating to his conduct during Partygate. He insists that he "did not lie" to the House of Commons and always made statements in good faith. MPs back Rishi Sunak's new Brexit deal for Northern Ireland by 515 votes to 29. Scotland's First Minister, Nicola Sturgeon, issues a "sincere, heartfelt and unreserved" apology to people affected by the practice of forced adoption in Scotland during the 1950s, 1960s and 1970s. The RMT call off two strikes planned by staff at 14 train operators that were scheduled for 30 March and 1 April following discussions with the Rail Delivery Group. Prime Minister Rishi Sunak publishes details of his tax returns following calls for him to be more transparent about his finances. 23 March The Bank of England raises its key interest rate for the 11th consecutive time, from 4% to 4.25%, in response to the unexpected growth of inflation.
Sources: en.wikipedia.org
In 2000, a gene therapy "success" resulted in SCID patients with a functional immune system. These trials were stopped when it was discovered that two of ten patients in one trial had developed leukemia resulting from the insertion of the gene-carrying retrovirus near an oncogene. By 2007, four of the ten patients had developed leukemias. Work aimed at improving gene therapy is now focusing on modifying the viral vector to reduce the likelihood of oncogenesis and using zinc-finger nucleases to further target gene insertion. No leukemia cases have yet been seen in trials of ADA-SCID, which does not involve the gamma c gene that may be oncogenic when expressed by a retrovirus. From the treatments of Ashanthi DeSilva in 1990, which is considered gene therapy's first success until 2014, around 60 patients were treated for either ADA-SCID or X-SCID using retroviruses vectors. As previously mentioned, the occurrence of leukemia cases forced researchers to make changes to improve safety. In 2019, a new method using an altered version of the HIV virus as a lentivirus vector was reported in the treatment of eight children with X-SCID, and in 2021 the same method was used in 50 children with ADA-SCID, obtaining positive results in 48 of them. There are also some non-curative methods for treating SCID. Reverse isolation involves the use of laminar air flow and mechanical barriers to avoid physical contact with others in order to isolate the patient from any harmful pathogens present in the external environment.
Leghemoglobin is a molecular similar in structure to myoglobin that is currently being used in artificial meat products, such as the Impossible Burger, to simulate both the color and taste of meat. Similar in function to hemoglobin, leghemoglobin contains trace amounts of iron, but it is primarily found in plant roots.
== History == In 2006, Rich Reiff and George Fox purchased several publications from Reed Business Information's New Product Division, formerly known as Gordon Publications, with the backing of private equity provided by Catalyst Investors. Also in 2006, the company launched the FindGuru business-to-business-focused search engine as a revised and rebranded ReedLink tool originally available from Reed Business Information. In 2011, ABM acquired Continuity Insights and Vicon Publishing. Vicon Publishing was renamed by ABM to Vicon Business Media as a subsidiary operated out of New Hampshire. In 2013 ABM acquired eMedia Vitals. In 2014, the firm was sold by Catalyst to Owners Resource Group (ORG), a private equity firm based in Austin, Texas, for undisclosed terms. This acquisition was ORG's first foray in the media business. In March 2014, co-founder Richard Reiff left the firm, leaving the CEO position vacant, though there is an indication that Jim Lonergan was brought in as CEO by the new owner. In 2018, Lonergan was replaced by Bruce Cummings and the company rebranded, changing its name to Advantage Business Marketing. On June 11, 2019, Cummings told all employees that the company was filing for bankruptcy and immediately closing. Staff had until the end of the day to vacate the premises. No severance package was given to employees, customers lost much of what they'd purchased, and many vendors were never paid.
== Clinical relevance == Recurrent mutations in this gene have been associated to cases of diffuse large B-cell lymphoma. De novo gain-of-function mutations in this gene is associated with Baraitser-Winter syndrome.
=== Improving the lesions of extensive necrobiosis lipoidica === Necrobiosis lipoidica (NL) is chronic granulomatous disease of the skin. It involves shiny patches or plaques with a sclerotic center and inflammatory edge. It may appear on different parts of the body and specially, the front part of the legs. The atrophic scars remain after healing which can be inconvenient for patients. Nevertheless, new lesions may occur. Systemic therapy with abrocitinib was administered at 200 mg/day for 12 weeks and then reduced to 100 mg. A slight stomach ache accompanies the 200 mg dose and no adverse events occurred with the 100 mg dose. An improvement with the old lesions was obvious and no new lesions were observed. The inflammatory edges decreased and the lesions disappeared. Thus, abrocitinib is linked to improving the life quality of the patient.
Sources: en.wikipedia.org
=== 19th century === Mary Watson (1856–1933), one of the first two female chemistry students at the University of Oxford Margaret Seward (1864–1929), one of the first two female chemistry students at the University of Oxford; signed the 1904 petition to the Chemical Society Vera Bogdanovskaia (1868–1897), one of the first female Russian chemists Martina Casiano y Mayor (1881–1958), first female member of the Spanish Society of Physics and Chemistry Gerty Cori (1896–1957) Jewish Czech-American biochemist who was the first American to win a Nobel Prize in science Margot Dorenfeldt (1895–1986) First woman to graduate from Norwegian Institute of Technology (1919) Ida Freund (1863–1914), first woman to be a university chemistry lecturer in the United Kingdom Ellen Gleditsch (1879–1968), Norwegian radiochemist; Norway's second female professor Louise Hammarström (1849–1917), Swedish mineral chemist, first formally educated female Swedish chemist Edith Humphrey (1875–1978), Inorganic chemist, probably the first British woman to gain a doctorate in chemistry Julia Lermontova (1846–1919), Russian chemist, first Russian female doctorate in chemistry Laura Linton (1853–1915), American chemist, teacher, and physician Rachel Lloyd (1839–1900), First American female to earn a doctorate in chemistry, first regularly admitted female member of the American Chemical Society, studied sugar beets Muriel Wheldale Onslow (1880–1932), British biochemist Marie Pasteur (1826–1910), French chemist and bacteriologist Mary Engle Pennington (1872–1952), American chemist Agnes Pockels (1862–1935), German chemist Anna Sundström (1785–1871), Swedish chemist Clara Immerwahr (1870–1915), First woman to get her doctorate in chemistry in Germany Ellen Swallow Richards (1842–1911), American industrial and environmental chemist Anna Volkova (1800–1876), Russian chemist Nadezhda Olimpievna Ziber-Shumova (died 1914), Russian chemist Fanny Rysan Mulford Hitchcock (1851–1936), one of thirteen (American) women to graduate with a degree in chemistry in the 1800s, and the first to graduate with a doctorate in philosophy of chemistry. Her areas of focus were in entomology, fish osteology, and plant pathology.
EDE is a synthetic estrane steroid and the C3 and C17β heptanoate (enanthate) diester of estradiol. It is also known as estradiol 3,17β-heptanoate or as estra-1,3,5(10)-triene-3,17β-diol 3,17β-diheptanoate. EDE is structurally related to estradiol enanthate (estradiol 17β-heptanoate), which has a single heptanoate ester rather than two.
Fine Tubes is a UK-based designer and manufacturer of stainless steel, nickel, zirconium, and titanium alloy tubes, based in Estover, Plymouth, Devon. These highly specialized tubes are used in oil and gas power plants, nuclear power plants, airspace and aeronautics, large scale chemical-industrial manufacturing, medical practice (including implants), and high performance liquid chromatography. Sales for the company include: Munich, Germany; Orléans, France; New Delhi, India; and Houston, Texas. Of note, The company has supplied cooling tubes to the Large Hadron Collider at CERN. In 2012, Fine Tubes was acquired along with its sister company, by The Watermill Group, an investment firm in the USA. It now operates as a subsidiary of Tubes Holdco Limited.
== Diagnosis == The diagnosis of MADD needs to be considered in patients who have exercise induced myalgia, cramps and sometimes weakness. A mildly elevated creatine kinase may also occur. Exclusion of other muscular diseases such as McArdle's Disease and carnitine cycle abnormalities should occur. MADD may be identified if there is a lack of ammonia rise after forearm exercise testing. The diagnosis may then be confirmed with genetic testing.
Sources: en.wikipedia.org
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.
The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.
It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.
Human data are limited. Most evidence comes from animal experiments and from small or uncontrolled reports. The absence of large trials means clinical effects and safety are not firmly established.